Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous tranexamic acid for bleeding reduction in rhinoplasty
IRCT20210614051574N14Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Bleeding (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Bleeding. Started Nov 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20210614051574N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210614051574N14.